Bridgepoint Education (BPI) Cut to Strong Sell at ValuEngine

Share on StockTwits

ValuEngine lowered shares of Bridgepoint Education (NYSE:BPI) from a sell rating to a strong sell rating in a report released on Tuesday.

Other research analysts also recently issued research reports about the stock. Zacks Investment Research raised shares of Bridgepoint Education from a hold rating to a buy rating and set a $11.00 target price on the stock in a research report on Wednesday, February 20th. Barrington Research reissued a buy rating on shares of Bridgepoint Education in a research report on Tuesday, January 8th. Finally, TheStreet downgraded shares of Bridgepoint Education from a b- rating to a c+ rating in a research report on Tuesday, November 27th.

Shares of BPI opened at $6.52 on Tuesday. Bridgepoint Education has a 1-year low of $5.31 and a 1-year high of $13.63. The stock has a market cap of $170.11 million, a P/E ratio of 10.43, a P/E/G ratio of 2.32 and a beta of 2.22. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.83 and a quick ratio of 1.83.

Bridgepoint Education (NYSE:BPI) last announced its quarterly earnings data on Tuesday, March 12th. The company reported ($0.23) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.11). The company had revenue of $94.71 million for the quarter, compared to the consensus estimate of $102.20 million. Bridgepoint Education had a net margin of 2.32% and a return on equity of 12.26%. Research analysts forecast that Bridgepoint Education will post 0.27 EPS for the current fiscal year.

In other Bridgepoint Education news, Director Robert D. Hartman sold 5,925 shares of the firm’s stock in a transaction dated Thursday, February 28th. The shares were sold at an average price of $10.37, for a total transaction of $61,442.25. Following the transaction, the director now owns 66,871 shares of the company’s stock, valued at approximately $693,452.27. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 31.90% of the company’s stock.

Institutional investors have recently modified their holdings of the company. PEAK6 Investments LLC grew its position in shares of Bridgepoint Education by 34.3% in the 4th quarter. PEAK6 Investments LLC now owns 13,428 shares of the company’s stock worth $94,000 after buying an additional 3,428 shares during the last quarter. Brandywine Global Investment Management LLC purchased a new position in shares of Bridgepoint Education in the 4th quarter worth approximately $101,000. Russell Investments Group Ltd. purchased a new position in shares of Bridgepoint Education in the 3rd quarter worth approximately $197,000. Ibex Investors LLC purchased a new position in shares of Bridgepoint Education in the 3rd quarter worth approximately $206,000. Finally, Municipal Employees Retirement System of Michigan purchased a new position in shares of Bridgepoint Education in the 4th quarter worth approximately $227,000. 80.89% of the stock is currently owned by hedge funds and other institutional investors.

About Bridgepoint Education

Bridgepoint Education, Inc, together with its subsidiaries, provides postsecondary education services in the United States. Its academic institutions, Ashford University and University of the Rockies, offer associate's, bachelor's, master's, and doctoral degree programs in the disciplines of business, education, psychology, social sciences, and health sciences.

Further Reading: Understanding Specialty Certificates of Deposit

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Bridgepoint Education Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bridgepoint Education and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Cyberark Software Ltd  Receives Consensus Rating of “Buy” from Analysts
Cyberark Software Ltd Receives Consensus Rating of “Buy” from Analysts
Fennec Pharmaceuticals Inc  Receives Consensus Rating of “Buy” from Brokerages
Fennec Pharmaceuticals Inc Receives Consensus Rating of “Buy” from Brokerages
Douglas Emmett, Inc.  Receives Consensus Recommendation of “Hold” from Analysts
Douglas Emmett, Inc. Receives Consensus Recommendation of “Hold” from Analysts
Landec Co.  Expected to Announce Quarterly Sales of $149.93 Million
Landec Co. Expected to Announce Quarterly Sales of $149.93 Million
CubeSmart  Expected to Post Earnings of $0.41 Per Share
CubeSmart Expected to Post Earnings of $0.41 Per Share
-$0.33 Earnings Per Share Expected for Achieve Life Sciences Inc  This Quarter
-$0.33 Earnings Per Share Expected for Achieve Life Sciences Inc This Quarter


 
© 2006-2019 Zolmax.